E22.1 N97
Conditions
Interventions
Group 1: Study participants are hyperprolactinaemic female patients in reproductive age suffering from infertility. The diagnosis of hyperprolactinaemia is established by single measurements of serum
PRL and Pr in the middle of luteal phase), hysterosalpingography or sonohysterosalpyngography, analysis for related infections, laparoscopy and hysteroscopy when indicated, etc. Husband’s semen analys
Sponsors
Clinic of Gynaecology and Obstetrics Universty Clinical Centre Faculty of Medicine University of Nis Nis Serbia
Eligibility
Sex/Gender
Female
Age
19 Years to 42 Years
Inclusion criteria
Inclusion criteria: Patients with idiopathic hyperprolactinaemia suffering from infertility.
Exclusion criteria
Exclusion criteria: Exclusion criteria are: prolactinoma, macroprolactinaemia, prolactinoma, secondary hyperprolactinaemia (due to medicaments, hypthyreosis, renal or hepatic failure etc), polcystic ovary syndrome, female patients with mechanical factor of infertility, male factor of infertility.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Our main goal is to determine the success of the treatment for infertility in patients with idiopathic hyperprolactinaemia. This primary endpoint will be measured 18 months after the beginning of the treatment for hyperprolactinaemia and infertility. | — |
Secondary
| Measure | Time frame |
|---|---|
| We are also seeking for the reasons of unsuccessful treatment of infertility in patients with idiopathic hyperprolactinaemia who did not achieve pregnancy in spite of adequate treatment and well controlled serum prolactin levels. This secondary endpoint will be measured 18 months after the beginning of the treatment for hyperprolactinaemia and infertility. | — |
Countries
Serbia
Contacts
Public ContactRanko Kutlesic
Clinic of Gynaecology and Obstetrics University Clinical centre Faculty of Medicine University opf Nis
Outcome results
None listed